37.48 +0.00 (0.00%)
IART
Stock Details
Last Trade:37.48 Change:+0.00 (0.00%) Prev Close:37.48 Open: 37.29 Days Range:37.02 – 37.67 52 Week Range: 18.97 - 40.50 Volume:113294 P/E: 18.19EPS:2.06
View AllRecent Alerts 02/10/10
Recent Alert on 01/25/10 at 9:36am
Barrington Research Initiates Coverage on Integra LifeSciences (IART) with an Outperform; Growth Opportunites in End Markets
Barrington Research Initiates Coverage on Integra LifeSciences (IART) with an Outperform; Growth Opportunites in End Markets
Barrington Research initiates coverage on Integra LifeSciences (Nasdaq: IART) with an Outperform rating. Price target $47. Barrington analyst says, "We believe investors in IART will benefit from the de-leveraging of the balance sheet as the value... Read More
Recent Alert on 01/22/10 at 8:24am
Integra LifeSciences (IART) First Clinical for Coral Spinal System Performed
Integra LifeSciences (IART) First Clinical for Coral Spinal System Performed
Recent Alert on 01/22/10 at 8:24am
Integra LifeSciences (IART) First Clinical for Coral Spinal System Performed
Integra LifeSciences (IART) First Clinical for Coral Spinal System Performed
Recent Alert on 01/19/10 at 9:03am
Integra LifeSciences (IART) Subsidiary to Supply Light Systems to HealthTrust Purchasing Group
Integra LifeSciences (IART) Subsidiary to Supply Light Systems to HealthTrust Purchasing Group
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/10 at 4:01pm
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: Capital Research Global Investors
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: Capital Research Global Investors
View AllRecent Blog Posts
Blog Posts on 01/25/10 at 11:45am
Analyst Upgrades, Downgrades and Initiations: GD, ICE, IGT, SAP, STI, TMH, TSS ...
Analyst Upgrades, Downgrades and Initiations: GD, ICE, IGT, SAP, STI, TMH, TSS ...
Blog Posts on 11/19/09 at 11:37am
CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q
CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q